One notable exception to this is heritable PAH in which genetic mutations such as those in bone morphogenetic protein receptor type 2 (BMPR2) and other mutations are well-described (9–13) and may be used to assist in classification of patients. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.